乙胺过量:对2018年美国全国紧急情况数据库的分析
Faria Sami1, Sarah Berg2, Augustine M Manadan3
1Department of Internal Medicine, Cook County Health, 1950 West Polk Street, Chicago, IL, 60612, USA. faria.sami@cookcountyhealth.org.
Internal and emergency medicine
|March 6, 2024
概括
这项研究发现了亚美诺芬过量服用的新风险因素,包括大麻使用和血液/瘤诊断. 这些发现强调了对这些新出现的风险进行进一步调查的必要性.
科学领域:
- 紧急医疗 紧急医疗
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 乙氨基过量是严重的公共卫生问题.
- 已知的危险因素包括酒精,阿片类药物使用和情绪障碍.
- 需要确定乙氨基过量服用的额外危险因素至关重要.
研究的目的:
- 评估乙氨基过量服用的其他风险因素.
- 在急诊室 (ED) 设置中评估各种并发症和乙胺过量服用之间的关联.
主要方法:
- 使用2018年美国全国紧急情况部门样本 (NEDS) 进行的回顾性研究.
- 作为研究组,包括成人ED过量服用乙氨基的访问.
- 使用STATA 16.1.1.进行的多变量逻辑回归分析.
主要成果:
- 鉴定了27,792次因乙氨基过量服用而进行的ED访问.
- 相关因素包括年龄较小,女性性别,更高的ED费用,与酒精有关的疾病,焦虑症,大麻使用,血液学/瘤学诊断,情绪障碍,阿片类药物相关疾病和自杀企图/想法.
- 对于情绪障碍 (10.07),与酒精有关的障碍 (2.67),和大麻使用 (1.63),发现了显著调整的几率比率 (ORadj).
结论:
- 大麻使用和血液/瘤并发症是新发现的乙氨基过量风险因素.
- 这些发现令人担忧,因为大麻合法化和癌症发病率的增加.
- 临床医生,政策制定者和研究人员的进一步调查是优先考虑的.
相关概念视频
Prevention of Further Absorption of Poison
821
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
821
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Anticholinesterase Agents: Poisoning and Treatment
856
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
856
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62


